Bridging the Epidemics of Obesity and MASLD

Part 1: Expert lecture

Uncover the growing impact of MASLD and MASH on patient health and explore evidence-based strategies to slow disease progression. This initial discussion examines the complications of these increasingly common liver conditions and highlights the role of nutrition and lifestyle interventions in improving outcomes and supporting long-term liver health.

Learning objectives

• Identify the complications and health consequences associated with MASLD and MASH. 
• Evaluate the role of nutritional and lifestyle interventions in managing MASH and reducing disease progression. 

Part 2: Product Theatre sponsored by Boehringer Ingelheim

Presented by Jeffrey Schneider, MD, DABOM, this session equips clinicians with practical insights to support early identification, diagnosis, and management of obesity, helping improve outcomes, and deliver more comprehensive patient care.

Learning objectives

• Discuss how obesity increases the risk of MASLD/MASH and emphasizes the need for early identification, diagnosis, and management​.  
• Apply obesity management strategies to support optimal patient outcomes and long-term health.